Literature DB >> 16939934

Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia.

Louisa Degenhardt1, Emma Black, Courtney Breen, Raimondo Bruno, Stuart Kinner, Amanda Roxburgh, Craig Fry, Rebecca Jenkinson, Jeff Ward, James Fetherston, Josephine Weekley, Jane Fischer.   

Abstract

This paper examines population trends in morphine prescriptions in Australia, and contrasts them with findings from annual surveys with regular injecting drug users (IDU). Data on morphine prescriptions from 1995 to 2003 were obtained from the Drug Monitoring System (DRUMS) run by the Australian Government Department of Health and Ageing. Data collected from regular IDU as part of the Australian Illicit Drug Reporting System (IDRS) were analysed (2001 - 2004). The rate of morphine prescription per person aged 15 - 54 years increased by 89% across Australia between 1995 and 2003 (from 46.3 to 85.9 mg per person). Almost half (46%) of IDU surveyed in 2004 reported illicit morphine use, with the highest rates in jurisdictions where heroin was less available. Recent morphine injectors were significantly more likely to be male, unemployed, out of treatment and homeless in comparison to IDU who had not injected morphine. They were also more likely to have injected other pharmaceutical drugs and to report injection related problems. Among those who had injected morphine recently, the most commonly reported injecting harms were morphine dependence (38%), difficulty finding veins into which to inject (36%) and scarring or bruising (27%). Morphine use and injection is a common practice among regular IDU in Australia. In some cases, morphine may be a substitute for illicit heroin; in others, it may be being used to treat heroin dependence where other pharmacotherapies, such as methadone and buprenorphine, are perceived as being unavailable or undesirable by IDU. Morphine injection appears to be associated with polydrug use, and with it, a range of problems related to drug injection. Further research is required to monitor and reduce morphine diversion and related harms by such polydrug injectors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939934     DOI: 10.1080/09595230600868504

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  11 in total

1.  Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse.

Authors:  John S Brownstein; Traci C Green; Theresa A Cassidy; Stephen F Butler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

2.  Use of the Internet to Obtain Drugs without a Prescription Among Treatment-involved Adolescents and Young Adults.

Authors:  David S Festinger; Karen L Dugosh; Nicolle Clements; Anna B Flynn; Mathea Falco; A Thomas McLellan; Amelia M Arria
Journal:  J Child Adolesc Subst Abuse       Date:  2016-05-26

3.  Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

Authors:  Giuliano Zamparutti; Fabrizio Schifano; John M Corkery; Adenekan Oyefeso; A Hamid Ghodse
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

4.  Opioid dependence latent structure: two classes with differing severity?

Authors:  Fiona L Shand; Tim Slade; Louisa Degenhardt; Andrew Baillie; Elliot C Nelson
Journal:  Addiction       Date:  2010-12-06       Impact factor: 6.526

Review 5.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

6.  Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets.

Authors:  Stuart McLean; Raimondo Bruno; Susan Brandon; Barbara de Graaff
Journal:  Harm Reduct J       Date:  2009-12-22

Review 7.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

8.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.

Authors:  Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin
Journal:  Addict Behav       Date:  2016-08-30       Impact factor: 3.913

9.  Prescription Opioid Injection Among HIV-Positive People Who Inject Drugs in a Canadian Setting.

Authors:  Stephanie Lake; Thomas Kerr; Jane Buxton; Silvia Guillemi; Surita Parashar; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Behav       Date:  2016-12

10.  Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study.

Authors:  Gabrielle Campbell; Richard Mattick; Raimondo Bruno; Briony Larance; Suzanne Nielsen; Milton Cohen; Nicholas Lintzeris; Fiona Shand; Wayne D Hall; Bianca Hoban; Chyanne Kehler; Michael Farrell; Louisa Degenhardt
Journal:  BMC Pharmacol Toxicol       Date:  2014-03-20       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.